Deirdre Renee Claytor

Array ( [id] => 6447839 [patent_doc_number] => 20100144864 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-06-10 [patent_title] => 'SOLUBLE GUANYLATE CYCLASE (SGC) MODULATORS FOR TREATMENT OF LIPID RELATED DISORDERS' [patent_app_type] => utility [patent_app_number] => 12/594744 [patent_app_country] => US [patent_app_date] => 2008-04-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15644 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0144/20100144864.pdf [firstpage_image] =>[orig_patent_app_number] => 12594744 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7685225 [patent_doc_number] => 20100120916 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-05-13 [patent_title] => 'THERAPEUTIC AGENT AND DIAGNOSTIC AGENT FOR MITOCHONDRIAL DYSFUNCTION BRAIN DISEASES' [patent_app_type] => utility [patent_app_number] => 12/594672 [patent_app_country] => US [patent_app_date] => 2008-03-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 6570 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0120/20100120916.pdf [firstpage_image] =>[orig_patent_app_number] => 12594672 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6537836 [patent_doc_number] => 20100204258 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-08-12 [patent_title] => 'METHODS AND COMPOSITIONS FOR MODULATING INSULIN SECRETION AND GLUCOSE METABOLISM' [patent_app_type] => utility [patent_app_number] => 12/450100 [patent_app_country] => US [patent_app_date] => 2008-03-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 9027 [patent_no_of_claims] => 44 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0204/20100204258.pdf [firstpage_image] =>[orig_patent_app_number] => 12450100 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8653085 [patent_doc_number] => 08372834 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-02-12 [patent_title] => 'Compositions and methods for delivery of anti-cancer agents' [patent_app_type] => utility [patent_app_number] => 12/529635 [patent_app_country] => US [patent_app_date] => 2008-02-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 10083 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 51 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12529635 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6631216 [patent_doc_number] => 20100311767 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-12-09 [patent_title] => 'Method for the treatment of amyloidoses' [patent_app_type] => utility [patent_app_number] => 12/529331 [patent_app_country] => US [patent_app_date] => 2008-02-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 33 [patent_figures_cnt] => 33 [patent_no_of_words] => 15621 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0311/20100311767.pdf [firstpage_image] =>[orig_patent_app_number] => 12529331 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6466679 [patent_doc_number] => 20100190792 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-07-29 [patent_title] => 'METHODS FOR TREATING COGNITIVE DISORDERS USING 1-BENZYL-1-HYDROXY-2,3-DIAMINO-PROPYL AMINES, 3-BENZYL-3-HYDROXY-2-AMINO-PROPIONIC ACID AMIDES AND RELATED COMPOUNDS' [patent_app_type] => utility [patent_app_number] => 12/530104 [patent_app_country] => US [patent_app_date] => 2008-02-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10231 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0190/20100190792.pdf [firstpage_image] =>[orig_patent_app_number] => 12530104 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6455101 [patent_doc_number] => 20100105687 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-04-29 [patent_title] => 'METHODS FOR TREATING COGNITIVE DISORDERS USING 1-ARYL-1-HYDROXY-2,3-DIAMINO-PROPYL AMINES, 1-HETEROARYL-1-HYDROXY-2,3-DIAMINO-PROPYL AMINES AND RELATED COMPOUNDS' [patent_app_type] => utility [patent_app_number] => 12/530141 [patent_app_country] => US [patent_app_date] => 2008-02-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12883 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0105/20100105687.pdf [firstpage_image] =>[orig_patent_app_number] => 12530141 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4832922 [patent_doc_number] => 20080131469 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-06-05 [patent_title] => 'Aqueous composition for cosmetics and cosmetic including the same' [patent_app_type] => utility [patent_app_number] => 12/021077 [patent_app_country] => US [patent_app_date] => 2008-01-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16494 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0131/20080131469.pdf [firstpage_image] =>[orig_patent_app_number] => 12021077 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6375031 [patent_doc_number] => 20100075972 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-03-25 [patent_title] => 'AGENT FOR TREATMENT OF MULTIPLE SCLEROSIS' [patent_app_type] => utility [patent_app_number] => 12/516595 [patent_app_country] => US [patent_app_date] => 2008-01-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 2922 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0075/20100075972.pdf [firstpage_image] =>[orig_patent_app_number] => 12516595 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6617459 [patent_doc_number] => 20100099774 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-04-22 [patent_title] => 'Method for Controlling Harmful Fungi' [patent_app_type] => utility [patent_app_number] => 12/523804 [patent_app_country] => US [patent_app_date] => 2008-01-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26776 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0099/20100099774.pdf [firstpage_image] =>[orig_patent_app_number] => 12523804 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6630277 [patent_doc_number] => 20100004325 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-01-07 [patent_title] => 'Use of Baicalein As Prolyl Hydroxylase 2 Inhibitor' [patent_app_type] => utility [patent_app_number] => 12/017535 [patent_app_country] => US [patent_app_date] => 2008-01-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 4614 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0004/20100004325.pdf [firstpage_image] =>[orig_patent_app_number] => 12017535 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7795934 [patent_doc_number] => 08124640 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-02-28 [patent_title] => 'Pharmaceutical composition based on idazoxan, salts, hydrates or polymorphs thereof' [patent_app_type] => utility [patent_app_number] => 12/015788 [patent_app_country] => US [patent_app_date] => 2008-01-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 9201 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 76 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/124/08124640.pdf [firstpage_image] =>[orig_patent_app_number] => 12015788 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4903497 [patent_doc_number] => 20080112910 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-05-15 [patent_title] => 'Cool feeling composition, cool feeling auxiliary composition, and use thereof' [patent_app_type] => utility [patent_app_number] => 12/003609 [patent_app_country] => US [patent_app_date] => 2007-12-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12103 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0112/20080112910.pdf [firstpage_image] =>[orig_patent_app_number] => 12003609 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6499679 [patent_doc_number] => 20100286216 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-11 [patent_title] => 'COMPOSITION HAVING A HIGH OSMOTIC ACTIVITY AND EXHIBITING ANTIMICROBIAL, ANTI-INFLAMMATORY, AND REGENERATIVE EFFECTS' [patent_app_type] => utility [patent_app_number] => 12/735245 [patent_app_country] => US [patent_app_date] => 2007-12-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2149 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0286/20100286216.pdf [firstpage_image] =>[orig_patent_app_number] => 12735245 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4894035 [patent_doc_number] => 20080103134 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-05-01 [patent_title] => 'Use of selected CGRP-antagonists in combination with other antimigraine drugs for the treatment of migraine' [patent_app_type] => utility [patent_app_number] => 11/962633 [patent_app_country] => US [patent_app_date] => 2007-12-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11837 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0103/20080103134.pdf [firstpage_image] =>[orig_patent_app_number] => 11962633 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8834579 [patent_doc_number] => 08450336 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-05-28 [patent_title] => 'Use of D-serine derivatives for the treatment of anxiety disorders' [patent_app_type] => utility [patent_app_number] => 12/519041 [patent_app_country] => US [patent_app_date] => 2007-12-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10333 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12519041 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6448238 [patent_doc_number] => 20100280064 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-04 [patent_title] => 'PHARMACEUTICAL COMPOSITION HAVING IMPROVED STORAGE STABILITY' [patent_app_type] => utility [patent_app_number] => 12/312966 [patent_app_country] => US [patent_app_date] => 2007-12-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3547 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0280/20100280064.pdf [firstpage_image] =>[orig_patent_app_number] => 12312966 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6606396 [patent_doc_number] => 20100063164 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-03-11 [patent_title] => 'TRANSPARENT ZINC SULPHIDE HAVING A HIGH SPECIFIC SURFACE AREA' [patent_app_type] => utility [patent_app_number] => 12/515973 [patent_app_country] => US [patent_app_date] => 2007-12-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3087 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0063/20100063164.pdf [firstpage_image] =>[orig_patent_app_number] => 12515973 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 64122 [patent_doc_number] => 07759378 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-07-20 [patent_title] => 'Polyamino acid derivatives and use thereof in compositions for treating keratin fibers' [patent_app_type] => utility [patent_app_number] => 11/984382 [patent_app_country] => US [patent_app_date] => 2007-11-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4344 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/759/07759378.pdf [firstpage_image] =>[orig_patent_app_number] => 11984382 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5973266 [patent_doc_number] => 20110152362 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-06-23 [patent_title] => 'METHODS OF TREATING EPILEPTOGENESIS AND EPILEPSY' [patent_app_type] => utility [patent_app_number] => 11/940710 [patent_app_country] => US [patent_app_date] => 2007-11-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 29101 [patent_no_of_claims] => 87 [patent_no_of_ind_claims] => 16 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0152/20110152362.pdf [firstpage_image] =>[orig_patent_app_number] => 11940710 [rel_patent_id] =>[rel_patent_doc_number] =>)